Transdermal Delivery
Researchers from General Hospital detail findings in transdermal delivery
Published in Hospital Law Weekly, November 8th, 2007
New research, 'Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison,' is the subject of a report. According to recent research from Klagenfurt, Austria, " In 2001, a transdermal matrix patch formulation of buprenorphine was approved for the treatment of moderate to severe cancer pain and severe pain that is unresponsive to nonopioid analgesics. The primary recommendation contained in the prescribing information was that transdermal patches be worn for a 3-day period before application of a new patch."
"This study was conducted to evaluate the potential for extending...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2007-11-08)
More Articles from Hospital Law Weekly
- Active Power, Inc.
Active Power Helps Support Metro Hospital in Achieving LEED Certification - Aging
'Will You Still Love Me, Will You Still Need Me, When I'm 84?' - Alzheimer Disease
AliMed's(R) Alzheimer's Resource Guide Provides Caregivers Practical, Simple Solutions to Preserve Quality of Life - Angioplasty
Cardiac Patients and Doctors Implore State to Abandon Dangerous Heart Experiment - Behavior
Reports on behavior findings from University of Leicester provide new insights - Cord Blood
Findings from Kaplan Medical Center provide new insights into cord blood - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
